Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1970 1
1974 1
1975 1
1976 1
1980 1
1986 1
1989 1
1993 1
1996 1
1997 1
2002 1
2004 2
2005 1
2006 1
2009 1
2010 1
2011 2
2012 3
2013 4
2014 10
2015 20
2016 20
2017 26
2018 30
2019 39
2020 59
2021 58
2022 43
2023 33
2024 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

335 results

Results by year

Filters applied: . Clear all
Page 1
Epilepsy and cannabidiol: a guide to treatment.
Arzimanoglou A, Brandl U, Cross JH, Gil-Nagel A, Lagae L, Landmark CJ, Specchio N, Nabbout R, Thiele EA, Gubbay O, The Cannabinoids International Experts Panel; Collaborators. Arzimanoglou A, et al. Epileptic Disord. 2020 Feb 1;22(1):1-14. doi: 10.1684/epd.2020.1141. Epileptic Disord. 2020. PMID: 32096470 Free article. Review.
Medical Cannabis in Children.
Aran A, Cayam-Rand D. Aran A, et al. Rambam Maimonides Med J. 2020 Jan 30;11(1):e0003. doi: 10.5041/RMMJ.10386. Rambam Maimonides Med J. 2020. PMID: 32017680 Free PMC article. Review.
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
Solmi M, De Toffol M, Kim JY, Choi MJ, Stubbs B, Thompson T, Firth J, Miola A, Croatto G, Baggio F, Michelon S, Ballan L, Gerdle B, Monaco F, Simonato P, Scocco P, Ricca V, Castellini G, Fornaro M, Murru A, Vieta E, Fusar-Poli P, Barbui C, Ioannidis JPA, Carvalho AF, Radua J, Correll CU, Cortese S, Murray RM, Castle D, Shin JI, Dragioti E. Solmi M, et al. BMJ. 2023 Aug 30;382:e072348. doi: 10.1136/bmj-2022-072348. BMJ. 2023. PMID: 37648266 Free PMC article.
Cannabidiol: pharmacology and therapeutic targets.
Britch SC, Babalonis S, Walsh SL. Britch SC, et al. Psychopharmacology (Berl). 2021 Jan;238(1):9-28. doi: 10.1007/s00213-020-05712-8. Epub 2020 Nov 21. Psychopharmacology (Berl). 2021. PMID: 33221931 Free PMC article. Review.
Cannabis and epilepsy.
Thomas RH, Cunningham MO. Thomas RH, et al. Pract Neurol. 2018 Dec;18(6):465-471. doi: 10.1136/practneurol-2018-002058. Epub 2018 Oct 18. Pract Neurol. 2018. PMID: 30337476 Review.
An Overview of Cannabidiol.
Sideris A, Doan LV. Sideris A, et al. Anesth Analg. 2024 Jan 1;138(1):54-68. doi: 10.1213/ANE.0000000000006584. Epub 2023 Dec 15. Anesth Analg. 2024. PMID: 38108806 Review.
Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity.
Rosenberg EC, Chamberland S, Bazelot M, Nebet ER, Wang X, McKenzie S, Jain S, Greenhill S, Wilson M, Marley N, Salah A, Bailey S, Patra PH, Rose R, Chenouard N, Sun SED, Jones D, Buzsáki G, Devinsky O, Woodhall G, Scharfman HE, Whalley BJ, Tsien RW. Rosenberg EC, et al. Neuron. 2023 Apr 19;111(8):1282-1300.e8. doi: 10.1016/j.neuron.2023.01.018. Epub 2023 Feb 13. Neuron. 2023. PMID: 36787750 Free article.
Cannabinoids in Pediatrics.
Campbell CT, Phillips MS, Manasco K. Campbell CT, et al. J Pediatr Pharmacol Ther. 2017 May-Jun;22(3):176-185. doi: 10.5863/1551-6776-22.3.176. J Pediatr Pharmacol Ther. 2017. PMID: 28638299 Free PMC article. Review.
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Pedrazzi JFC, Ferreira FR, Silva-Amaral D, Lima DA, Hallak JEC, Zuardi AW, Del-Bel EA, Guimarães FS, Costa KCM, Campos AC, Crippa ACS, Crippa JAS. Pedrazzi JFC, et al. Psychopharmacology (Berl). 2022 Sep;239(9):2713-2734. doi: 10.1007/s00213-022-06196-4. Epub 2022 Jul 29. Psychopharmacology (Berl). 2022. PMID: 35904579 Review.
Addictive neurons.
Kodirov SA. Kodirov SA. Ther Targets Neurol Dis. 2017;4:e1498. Epub 2017 Jan 30. Ther Targets Neurol Dis. 2017. PMID: 28649663 Free PMC article.
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
Devinsky O, Marsh E, Friedman D, Thiele E, Laux L, Sullivan J, Miller I, Flamini R, Wilfong A, Filloux F, Wong M, Tilton N, Bruno P, Bluvstein J, Hedlund J, Kamens R, Maclean J, Nangia S, Singhal NS, Wilson CA, Patel A, Cilio MR. Devinsky O, et al. Lancet Neurol. 2016 Mar;15(3):270-8. doi: 10.1016/S1474-4422(15)00379-8. Epub 2015 Dec 24. Lancet Neurol. 2016. PMID: 26724101 Clinical Trial.
Cannabinoids in Neurologic Illnesses.
Patel AD. Patel AD. Neurol Clin. 2021 Feb;39(1):231-241. doi: 10.1016/j.ncl.2020.09.012. Epub 2020 Nov 7. Neurol Clin. 2021. PMID: 33223086 Review.
Cannabis for Pediatric Epilepsy.
Huntsman RJ, Tang-Wai R, Shackelford AE. Huntsman RJ, et al. J Clin Neurophysiol. 2020 Jan;37(1):2-8. doi: 10.1097/WNP.0000000000000641. J Clin Neurophysiol. 2020. PMID: 31895184 Review.
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial.
Knight EMP, Amin S, Bahi-Buisson N, Benke TA, Cross JH, Demarest ST, Olson HE, Specchio N, Fleming TR, Aimetti AA, Gasior M, Devinsky O; Marigold Trial Group. Knight EMP, et al. Lancet Neurol. 2022 May;21(5):417-427. doi: 10.1016/S1474-4422(22)00077-1. Lancet Neurol. 2022. PMID: 35429480 Clinical Trial.
The clinical toxicology of cannabis.
Schep LJ, Slaughter RJ, Glue P, Gee P. Schep LJ, et al. N Z Med J. 2020 Oct 9;133(1523):96-103. N Z Med J. 2020. PMID: 33032307 Review.
Review: Cannabinoids as Medicinals.
Khalsa JH, Bunt G, Blum K, Maggirwar SB, Galanter M, Potenza MN. Khalsa JH, et al. Curr Addict Rep. 2022;9(4):630-646. doi: 10.1007/s40429-022-00438-3. Epub 2022 Sep 7. Curr Addict Rep. 2022. PMID: 36093358 Free PMC article. Review.
[Cannabis is not for children or adolescents].
Opstrup P, Olsen M, Nysom K, Uldall PV, Walther-Larsen S. Opstrup P, et al. Ugeskr Laeger. 2017 Oct 16;179(42):V07170527. Ugeskr Laeger. 2017. PMID: 29053095 Free article. Review. Danish.
Epilepsy and cannabis: so near, yet so far.
Kirkpatrick M, O'callaghan F. Kirkpatrick M, et al. Dev Med Child Neurol. 2022 Feb;64(2):162-167. doi: 10.1111/dmcn.15032. Epub 2021 Sep 8. Dev Med Child Neurol. 2022. PMID: 34498262 Free article. Review.
Cannabinoid therapy in epilepsy.
Billakota S, Devinsky O, Marsh E. Billakota S, et al. Curr Opin Neurol. 2019 Apr;32(2):220-226. doi: 10.1097/WCO.0000000000000660. Curr Opin Neurol. 2019. PMID: 30676535 Review.
Améliorer la réglementation du cannabis médical au Canada pour mieux servir les patients pédiatriques.
Huntsman RJ, Kelly LE, Alcorn J, Appendino JP, Bélanger RE, Crooks B, Finkelstein Y, Gilpin A, Lewis E, Litalien C, Jacobs J, Moore-Hepburn C, Oberlander T, Rassekh SR, Repetski AE, Rieder MJ, Shackelford A, Siden H, Szafron M, 't Jong GW, Vaillancourt R; pour la Cannabinoid Research Initiative of Saskatchewan et le Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial). Huntsman RJ, et al. CMAJ. 2021 Dec 6;193(48):E1864-E1867. doi: 10.1503/cmaj.202169-f. CMAJ. 2021. PMID: 34872964 Free PMC article. French. No abstract available.
Position Statement on the Use of Medical Cannabis for the Treatment of Epilepsy in Canada.
Appendino JP, Boelman C, Brna PM, Burneo JG, Claassen CS, Connolly MB, De Guzman MVT, Federico P, Floyd D, Huntsman RJ, Javidan M, Jette N, Jurasek LL, Keezer MR, Lau JC, McCoy B, McLachlan RS, Ng MC, Nguyen DK, Reid AY, Rho JM, Snead OC, Téllez-Zenteno JF, Wang L, Zak MM. Appendino JP, et al. Can J Neurol Sci. 2019 Nov;46(6):645-652. doi: 10.1017/cjn.2019.282. Can J Neurol Sci. 2019. PMID: 31466531 Review.
Medical Cannabis in Pediatric Oncology: Friend or Foe?
Malach M, Kovalchuk I, Kovalchuk O. Malach M, et al. Pharmaceuticals (Basel). 2022 Mar 16;15(3):359. doi: 10.3390/ph15030359. Pharmaceuticals (Basel). 2022. PMID: 35337156 Free PMC article. Review.
Cannabinoids in treatment-resistant epilepsy: A review.
O'Connell BK, Gloss D, Devinsky O. O'Connell BK, et al. Epilepsy Behav. 2017 May;70(Pt B):341-348. doi: 10.1016/j.yebeh.2016.11.012. Epub 2017 Feb 8. Epilepsy Behav. 2017. PMID: 28188044 Review.
Epilepsy and cannabis: facing reality.
Ben-Zeev B. Ben-Zeev B. Dev Med Child Neurol. 2022 Feb;64(2):272. doi: 10.1111/dmcn.15081. Epub 2021 Oct 29. Dev Med Child Neurol. 2022. PMID: 34713904 Free article. No abstract available.
Plant-Derived and Endogenous Cannabinoids in Epilepsy.
Verrotti A, Castagnino M, Maccarrone M, Fezza F. Verrotti A, et al. Clin Drug Investig. 2016 May;36(5):331-40. doi: 10.1007/s40261-016-0379-x. Clin Drug Investig. 2016. PMID: 26892745 Review.
Adult Phenotype of SYNGAP1-DEE.
Rong M, Benke T, Zulfiqar Ali Q, Aledo-Serrano Á, Bayat A, Rossi A, Devinsky O, Qaiser F, Ali AS, Fasano A, Bassett AS, Andrade DM. Rong M, et al. Neurol Genet. 2023 Nov 17;9(6):e200105. doi: 10.1212/NXG.0000000000200105. eCollection 2023 Dec. Neurol Genet. 2023. PMID: 38045990 Free PMC article.
Efficacy of cannabinoids in paediatric epilepsy.
Ali S, Scheffer IE, Sadleir LG. Ali S, et al. Dev Med Child Neurol. 2019 Jan;61(1):13-18. doi: 10.1111/dmcn.14087. Epub 2018 Nov 6. Dev Med Child Neurol. 2019. PMID: 30402932 Free article. Review.
Medical marijuana and children.
Stubblefield S. Stubblefield S. Del Med J. 2014 Nov;86(11):345-9. Del Med J. 2014. PMID: 25647865
Is the medical use of cannabis a therapeutic option for children?
Rieder MJ; Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee. Rieder MJ, et al. Paediatr Child Health. 2016 Jan-Feb;21(1):31-4. doi: 10.1093/pch/21.1.31. Paediatr Child Health. 2016. PMID: 26941559 Free PMC article.
Cannabidiol: promise and pitfalls.
Welty TE, Luebke A, Gidal BE. Welty TE, et al. Epilepsy Curr. 2014 Sep;14(5):250-2. doi: 10.5698/1535-7597-14.5.250. Epilepsy Curr. 2014. PMID: 25346628 Free PMC article.
Cannabis: are there any benefits?
Vickery AW, Finch PM. Vickery AW, et al. Intern Med J. 2020 Nov;50(11):1326-1332. doi: 10.1111/imj.15052. Intern Med J. 2020. PMID: 33215831
Addiction in pregnancy.
Keegan J, Parva M, Finnegan M, Gerson A, Belden M. Keegan J, et al. J Addict Dis. 2010 Apr;29(2):175-91. doi: 10.1080/10550881003684723. J Addict Dis. 2010. PMID: 20407975
Phytocannabinoids in neuromodulation: From omics to epigenetics.
Banerjee S, Saha D, Sharma R, Jaidee W, Puttarak P, Chaiyakunapruk N, Chaoroensup R. Banerjee S, et al. J Ethnopharmacol. 2024 Aug 10;330:118201. doi: 10.1016/j.jep.2024.118201. Epub 2024 Apr 26. J Ethnopharmacol. 2024. PMID: 38677573 Review.
The cannabis experiment.
Cressey D. Cressey D. Nature. 2015 Aug 20;524(7565):280-3. doi: 10.1038/524280a. Nature. 2015. PMID: 26295084 No abstract available.
Use of non-medical cannabis in epilepsy: A scoping review.
Li J, Areal CC, Toffa DH, Citherlet D, Deacon C, Jutras-Aswad D, Keezer MR, Nguyen DK. Li J, et al. Front Neurol. 2023 Mar 6;14:1132106. doi: 10.3389/fneur.2023.1132106. eCollection 2023. Front Neurol. 2023. PMID: 36949852 Free PMC article.
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder.
Olson HE, Daniels CI, Haviland I, Swanson LC, Greene CA, Denny AMM, Demarest ST, Pestana-Knight E, Zhang X, Moosa AN, Fidell A, Weisenberg JL, Suter B, Fu C, Neul JL, Percy AK, Marsh ED, Benke TA, Poduri A. Olson HE, et al. J Neurodev Disord. 2021 Sep 16;13(1):40. doi: 10.1186/s11689-021-09384-z. J Neurodev Disord. 2021. PMID: 34530725 Free PMC article.
Use of Integrative, Complementary, and Alternative Medicine in Children with Epilepsy: A Global Scoping Review.
Zhu Z, Dluzynski D, Hammad N, Pugalenthi D, Walser SA, Mittal R, Samanta D, Brown ML, Asadi-Pooya AA, Kakooza-Mwesige A, Spalice A, Capponi M, Lekoubou A, Kumar A, Paudel S, Carney PR, Mainali G, Naik S. Zhu Z, et al. Children (Basel). 2023 Apr 12;10(4):713. doi: 10.3390/children10040713. Children (Basel). 2023. PMID: 37189961 Free PMC article. Review.
Cannabidiol Treatment for Refractory Epilepsies in Pediatrics.
Raucci U, Pietrafusa N, Paolino MC, Di Nardo G, Villa MP, Pavone P, Terrin G, Specchio N, Striano P, Parisi P. Raucci U, et al. Front Pharmacol. 2020 Sep 29;11:586110. doi: 10.3389/fphar.2020.586110. eCollection 2020. Front Pharmacol. 2020. PMID: 33117180 Free PMC article. Review.
Cannabidiol activates neuronal Kv7 channels.
Zhang HB, Heckman L, Niday Z, Jo S, Fujita A, Shim J, Pandey R, Al Jandal H, Jayakar S, Barrett LB, Smith J, Woolf CJ, Bean BP. Zhang HB, et al. Elife. 2022 Feb 18;11:e73246. doi: 10.7554/eLife.73246. Elife. 2022. PMID: 35179483 Free PMC article.
What's in a name?
Tolchin B, Perez DL, Szaflarski JP, Baslet G, Doss J, Buchhalter J, Sawchuk T, Dworetzky BA. Tolchin B, et al. Epilepsy Behav. 2020 Nov;112:107364. doi: 10.1016/j.yebeh.2020.107364. Epub 2020 Aug 22. Epilepsy Behav. 2020. PMID: 32843303 No abstract available.
Aplicaciones terapéuticas por acción de los cannabinoides.
Plancarte-Sánchez R, Mansilla-Olivares A, De Los Reyes-Pacheco VA, Meneses-González F. Plancarte-Sánchez R, et al. Gac Med Mex. 2019;155(3):307-318. doi: 10.24875/GMM.18004928. Gac Med Mex. 2019. PMID: 31219471 Free article. Review.
Parents' experiences using medical cannabis for their child.
Ryan JE, Smeltzer SC, Sharts-Hopko NC. Ryan JE, et al. Nurs Outlook. 2020 May-Jun;68(3):337-344. doi: 10.1016/j.outlook.2019.12.004. Epub 2020 Apr 23. Nurs Outlook. 2020. PMID: 32334826 Free PMC article.
The Potential Proconvulsant Effects of Cannabis: a Scoping Review.
Kaczor EE, Greene K, Zacharia J, Tormoehlen L, Neavyn M, Carreiro S. Kaczor EE, et al. J Med Toxicol. 2022 Jul;18(3):223-234. doi: 10.1007/s13181-022-00886-3. Epub 2022 Mar 29. J Med Toxicol. 2022. PMID: 35352276 Free PMC article. Review.
Update on Cannabidiol in Drug-Resistant Epilepsy.
Singh A, Madaan P, Bansal D. Singh A, et al. Indian J Pediatr. 2024 Nov 25. doi: 10.1007/s12098-024-05337-1. Online ahead of print. Indian J Pediatr. 2024. PMID: 39585547 Review.
The potential role of cannabinoids in epilepsy treatment.
De Caro C, Leo A, Citraro R, De Sarro C, Russo R, Calignano A, Russo E. De Caro C, et al. Expert Rev Neurother. 2017 Nov;17(11):1069-1079. doi: 10.1080/14737175.2017.1373019. Epub 2017 Sep 4. Expert Rev Neurother. 2017. PMID: 28845714 Review.
Diverse genetic causes of polymicrogyria with epilepsy.
Epilepsy Phenome/Genome Project, Epi4K Consortium. Epilepsy Phenome/Genome Project, Epi4K Consortium. Epilepsia. 2021 Apr;62(4):973-983. doi: 10.1111/epi.16854. Epub 2021 Apr 5. Epilepsia. 2021. PMID: 33818783 Free PMC article.
Medical cannabis in schools: The experiences of caregivers.
Mansell H, Zaslawski Z, Mbabaali S, King PM, Kelly LE, Lougheed T, Anderson J, Huntsman RJ, Alcorn J. Mansell H, et al. Paediatr Child Health. 2023 May 4;28(2):102-106. doi: 10.1093/pch/pxac099. eCollection 2023 May. Paediatr Child Health. 2023. PMID: 37151922 Free PMC article.
Management of hallucinogen abuse.
Haddad LM. Haddad LM. Am Fam Physician. 1976 Jul;14(1):82-7. Am Fam Physician. 1976. PMID: 1065215
A Pediatric Hospital Policy for Medical Marijuana Use.
Carver AE, Jorgensen J, Barberio MW, Lomuscio CE, Brumbaugh D. Carver AE, et al. Pediatrics. 2020 Aug;146(2):e20194079. doi: 10.1542/peds.2019-4079. Epub 2020 Jul 13. Pediatrics. 2020. PMID: 32661191
Second-line cannabis therapy in patients with epilepsy.
Braun E, Gualano FM, Siddarth P, Segal E. Braun E, et al. Clin Neurol Neurosurg. 2023 Apr;227:107638. doi: 10.1016/j.clineuro.2023.107638. Epub 2023 Feb 21. Clin Neurol Neurosurg. 2023. PMID: 36870086
Cannabidiol Impairs Brain Mitochondrial Metabolism and Neuronal Integrity.
Drummond-Main CD, Ahn Y, Kesler M, Gavrilovici C, Kim DY, Kiroski I, Baglot SL, Chen A, Sharkey KA, Hill MN, Teskey GC, Rho JM. Drummond-Main CD, et al. Cannabis Cannabinoid Res. 2023 Apr;8(2):283-298. doi: 10.1089/can.2022.0011. Epub 2022 Sep 15. Cannabis Cannabinoid Res. 2023. PMID: 36108318 Free PMC article.
Neurological Aspects of Medical Use of Cannabidiol.
Mannucci C, Navarra M, Calapai F, Spagnolo EV, Busardò FP, Cas RD, Ippolito FM, Calapai G. Mannucci C, et al. CNS Neurol Disord Drug Targets. 2017;16(5):541-553. doi: 10.2174/1871527316666170413114210. CNS Neurol Disord Drug Targets. 2017. PMID: 28412918 Review.
Predicting risk and the emergence of schizophrenia.
Clarke MC, Kelleher I, Clancy M, Cannon M. Clarke MC, et al. Psychiatr Clin North Am. 2012 Sep;35(3):585-612. doi: 10.1016/j.psc.2012.06.003. Psychiatr Clin North Am. 2012. PMID: 22929868 Review.
Treatment of infantile spasms.
Hussain SA. Hussain SA. Epilepsia Open. 2018 Oct 23;3(Suppl Suppl 2):143-154. doi: 10.1002/epi4.12264. eCollection 2018 Dec. Epilepsia Open. 2018. PMID: 30564773 Free PMC article.
Trends in MDMA-related mortality across four countries.
Roxburgh A, Sam B, Kriikku P, Mounteney J, Castanera A, Dias M, Giraudon I. Roxburgh A, et al. Addiction. 2021 Nov;116(11):3094-3103. doi: 10.1111/add.15493. Epub 2021 Apr 15. Addiction. 2021. PMID: 33739562
Rhabdomyolysis related to acute recreational drug toxicity-A Euro-DEN study.
Waldman W, Kabata PM, Dines AM, Wood DM, Yates C, Heyerdahl F, Hovda KE, Giraudon I; Euro-DEN Research Group; Dargan PI, Sein Anand J. Waldman W, et al. PLoS One. 2021 Mar 11;16(3):e0246297. doi: 10.1371/journal.pone.0246297. eCollection 2021. PLoS One. 2021. PMID: 33705425 Free PMC article.
Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial.
Downs J, Jacoby P, Specchio N, Cross H, Amin S, Bahi-Buisson N, Rajaraman R, Suter B, Devinsky O, Aimetti A, Busse G, Olson HE, Demarest S, Benke TA, Pestana-Knight E. Downs J, et al. Eur J Paediatr Neurol. 2024 Jul;51:140-146. doi: 10.1016/j.ejpn.2024.06.005. Epub 2024 Jun 17. Eur J Paediatr Neurol. 2024. PMID: 38959712 Free PMC article. Clinical Trial.
[Use of cannabidiol oil in children].
Wolff D, Reijneveld SA. Wolff D, et al. Ned Tijdschr Geneeskd. 2019 May 3;163:D3145. Ned Tijdschr Geneeskd. 2019. PMID: 31120211 Dutch.
Risks and Benefits of Marijuana Use: A National Survey of U.S. Adults.
Keyhani S, Steigerwald S, Ishida J, Vali M, Cerdá M, Hasin D, Dollinger C, Yoo SR, Cohen BE. Keyhani S, et al. Ann Intern Med. 2018 Sep 4;169(5):282-290. doi: 10.7326/M18-0810. Epub 2018 Jul 24. Ann Intern Med. 2018. PMID: 30039154 Free PMC article.
Cannabis-based products for pediatric epilepsy: A systematic review.
Elliott J, DeJean D, Clifford T, Coyle D, Potter BK, Skidmore B, Alexander C, Repetski AE, Shukla V, McCoy B, Wells GA. Elliott J, et al. Epilepsia. 2019 Jan;60(1):6-19. doi: 10.1111/epi.14608. Epub 2018 Dec 4. Epilepsia. 2019. PMID: 30515765
Epidemiological and sociodemographic factors associated with complicated alcohol withdrawal syndrome.
Monte-Secades R, Blanco-Soto M, Díaz-Peromingo JA, Sanvisens-Bergé A, Martín-González MC, Barbosa A, Rosón-Hernández B, Tejero-Delgado MA, Puerta-Louro R, Rabuñal-Rey R; Grupo de Trabajo Alcohol y Alcoholismo, Sociedad Española de Medicina Interna. Monte-Secades R, et al. Rev Clin Esp (Barc). 2017 Oct;217(7):381-386. doi: 10.1016/j.rce.2017.05.002. Epub 2017 Jun 21. Rev Clin Esp (Barc). 2017. PMID: 28645616 English, Spanish.
Pediatric Death Due to Myocarditis After Exposure to Cannabis.
Nappe TM, Hoyte CO. Nappe TM, et al. Clin Pract Cases Emerg Med. 2017 Mar 16;1(3):166-170. doi: 10.5811/cpcem.2017.1.33240. eCollection 2017 Aug. Clin Pract Cases Emerg Med. 2017. PMID: 29849306 Free PMC article.
Removing barriers to accessing medical cannabis for paediatric patients.
Huntsman RJ, Elliott J, Lewis E, Moore-Hepburn C, Alcorn J, Mansell H, Appendino JP, Bélanger RE, Corley S, Crooks B, Denny AM, Finkelstein Y, Finley A, Fung R, Gilpin A, Litalien C, Jacobs J, Oberlander TF, Palm A, Palm J, Polewicz M, Quinn D, Rassekh SR, Repetski A, Rieder MJ, Robson-McKay A, Seifert B, Shackelford A, Siden H, Szafron M, 't Jong G, Vaillancourt R, Kelly LE. Huntsman RJ, et al. Paediatr Child Health. 2023 Mar 31;29(1):12-16. doi: 10.1093/pch/pxac129. eCollection 2024 Feb. Paediatr Child Health. 2023. PMID: 38332979 Free PMC article.
335 results